| 6.55 -0.065 (-0.98%) | 12-15 15:53 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.9 | 1-year : | 8.36 |
| Resists | First : | 6.76 | Second : | 7.15 |
| Pivot price | 6.72 |
|||
| Supports | First : | 6.13 | Second : | 5.1 |
| MAs | MA(5) : | 6.7 |
MA(20) : | 6.62 |
| MA(100) : | 6.91 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 61.2 |
D(3) : | 75.1 |
| RSI | RSI(14): 40.7 |
|||
| 52-week | High : | 8.3 | Low : | 5.09 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BTX ] has closed above bottom band by 2.1%. Bollinger Bands are 32.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.79 - 6.83 | 6.83 - 6.87 |
| Low: | 6.49 - 6.54 | 6.54 - 6.57 |
| Close: | 6.55 - 6.62 | 6.62 - 6.68 |
BlackRock Innovation and Growth Trust (the Trust) is a newly-organized, non-diversified, closed-end management investment company with no operating history. The Trusts investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. There can be no assurance that the Trusts investment objectives will be achieved or that the Trusts investment program will be successful The Trust will invest primarily in equity securities issued by mid- and small-capitalization companies that the Trusts adviser believes have above-average earnings growth potential. In selecting investments for the Trust, the Trusts adviser focuses on mid- and small-capitalization growth companies that are innovative. These are companies that have introduced, or are seeking to introduce, a new product or service that potentially changes the marketplace.
Thu, 11 Sep 2025
BlackRock Announces Update to BMEZ, BSTZ, and BTX Managed Distribution Plans - Yahoo Finance
Sat, 16 Aug 2025
BTX Offers Diversification Into Private Equity (NYSE:BTX) - Seeking Alpha
Fri, 01 Aug 2025
Press Release: Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds - 富途牛牛
Thu, 31 Jul 2025
AI Is Driving Huge Profits, These Are Best Dividends up to 13% - Contrarian Outlook
Thu, 10 Jul 2025
BlackRock Technology and Private Equity Term Trust (BTX) Announces Final Results of Tender Offer - The AI Journal
Mon, 23 Jun 2025
3 Beaten-Up Dividend Plays Now Offering Yields as High as 13.6% - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 117 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 9.3 (%) |
| Shares Short | 140 (K) |
| Shares Short P.Month | 196 (K) |
| EPS | 0.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 54.54 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0.05 |
| Forward Dividend | 0 |
| Dividend Yield | 0.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|